Sun Life and Medzown team up to expand access to clinical trials for cancer and other complex diseases

About this update from Sun Life Financial Inc.

The collaboration advances shared goals of improving members' health outcomes while reducing specialty drug cost exposure and delivering measurable results for self-funded employersBOSTON and WELLESLEY, Mass., June 16, 2026 /PRNewswire/ -- Sun Life U.S., the nation's largest independent stop-loss provider, and Medzown, Inc., a precision medicine management company, are collaborating to increase access to clinical trials for employees at self-insured employers across the country. Medzown improves access to advanced therapies and clinical trials for patients with cancer and other complex conditions, such as orthopedic/musculoskeletal (ortho/MSK). New and existing Sun Life stop-loss clients will have the opportunity to leverage Medzown's AI-powered clinical model to identify patients at a diagnostic or therapeutic crossroads and connect them to an appropriate clinical trial. This offers another touch point to address high-cost claims before they escalate, an increasingly common pattern with complex health conditions. Medzown is the latest addition to Sun Life's comprehensive suite of health solutions designed to improve health outcomes for members and drive down costs for clients.According to Sun Life's 2026 high-cost claims report, which analyzes drug treatment, healthcare and high-dollar medical claim trends, cancer costs an average of $252,000 per individual per year, while ortho/MSK costs an average of $120,000. Medzown's Predictive Population Analytics platform proactively recognizes members with rare diseases, oncology diagnoses and other complex conditions who may benefit from advanced treatment options, including enrollment in clinical trials."Sun Life stop-loss insurance is an invaluable safety net for self-funded employers to mitigate the financial impact of high-cost claims," said Dr. Jennifer Levin Carter, founder and CEO of Medzown. "Medzown's precision medicine capabilities extend that safety net to ensure members navigating a cancer diagnosis or rare disease have access to every medical intervention available. Together, we can offer a comprehensive solution for employers actively seeking smarter approaches to improve health outcomes, contain high-cost claims and ensure every patient has the support they need to manage a life-changing diagnosis."Medzown's proprietary approach prioritizes member engagement through cobranded outreach with th...

View stock analysis, news, and events for Sun Life Financial Inc.